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SOCIAL AND BEHAVIORAL FACTORS ASSOCIATED WITH INJECTION 
DRUG USE AMONG IRANIAN MEN LIVING IN KERMANSHAH CITY 
 
VIRA AMELI 
ABSTRACT 
 Iran is among the countries with the highest rates of opioid and heroin 
consumption in the world. Smoking opium among the Iranian population has historical 
and traditional roots; however the rising rate of injection drug use is a relatively new 
phenomenon. This project was designed as a retrospective case-comparison study, aiming 
to identify the social and behavioral factors that are associated with initiating injection 
drug use among a population of 948 male drug users, who sought addiction treatment at a 
methadone clinic in western Iran between February 1, 2004 and August 31, 2005.  
Logistic regression was employed to assess the statistically significant social and 
behavioral risk factors for injection drug use initiation. The study population included 
177 injecting drug users, constituting 18.67% of the total participants, and 771 non-
injecting drug users. The initial crude analysis of the data indicated that drug users who 
were younger, more educated, unemployed, addicted at a younger age, lived in an urban 
area, were not married and had no children, initiated smoking before the age of 20, had 
one addicted blood-relative, used drugs four times or more per day, ceased drug use while 
in prison or began with or used other drugs like buprenorphine, heroin, or marijuana were 
more likely to turn to injection drug use. However, after adjustment for confounding 
effects through logistic regression analysis only younger age, buprenorphine use, high 
	  	   vii 
daily frequency of drug use, and history of drug use cessation in prison camps, remained 
associated with initiating injection.  
Interestingly, the impact of the associated risk factors was considerably different 
between the participants who indicated their onset date of drug use as after versus prior to 
the year 2000, coinciding with the ban on poppy production in neighboring Afghanistan, 
which is the primary source of opiate import into Iran. Most notably, the subjects who 
initiated injection after 2000 were more likely to be highly educated, receiving at least a 
high school diploma or higher, whereas the group that initiated drug use prior to the year 
2000 were shown to have a significantly higher rate of imprisonment and attempts at 
quitting in law-enforced rehabilitation facilities. It was also demonstrated that the 
population who began drug use after the year 2000 had an increased shift towards using 
buprenorphine, which is highly associated with increasing the drive towards injection, 
and increasing the prevalence of the associated infections such as human 
immunodeficiency virus (HIV), Hepatitis C Virus (HCV), and other injection-associated 
adverse health outcomes.  
This analysis elucidated that changes in policy and governmental control 
measures could indirectly influence the choices and behaviors of drug users, 
demonstrating the interplay between social and behavioral factors. Therefore, in order to 
minimize detrimental effects of policy changes, harm reduction interventions must be 
dynamic and cater to the needs of target populations who are at risk of opting for drug 
use behaviors that could be more harmful to their long-term health. Factors such as date 
of addiction initiation may indirectly affect the risk of injection initiation, and 
	  	   viii 
information on these factors can guide us to identify and assess other contextual factors 
that may have an impact on the significance of risk factors that could lead to injection 
initiation. This observation is especially significant in the context of addiction in a 
country such as Iran, with a constantly changing economy. Caution must therefore be 
applied to not group drug using populations in a single category when designing public 
policy, health interventions, or treatment measures. Therefore, identifying the risk factors 
for injection initiation in the context of environmental and societal changes is of utmost 
importance in order to provide appropriate harm reduction solutions for those who have 
yet to inject and are at highest risk for injecting. 
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INTRODUCTION 
 
 History of Drug Use in Iran  
The Islamic Republic of Iran is a unique case study of drug use behavior.1,2 The 
country’s long history of opium use dates back to 330 BC, when Alexander the Great 
introduced opium to Iran, and remained popular thereafter.3 The proximity and porous 
borders with Afghanistan, are also  major factors contributing to the high rates of opiate 
dependence in Iran, which are today at the highest global levels1, 4 with 1 in 17 citizens a 
regular drug user and 20% of Iranians aged 15 to 60 involved in drug use.5,6 The UNODC 
7 estimates that the largest volume of opium (42% of global opiate consumption) is 
consumed by Iran and that roughly 2 million (2.8%) of its 70 million people are opiate 
dependent.8, 9  
While historically opium and Shire (a concentrated form of opium) were often 
taken by smoking or ingestion,10 the recent profile of drug users in Iran has shown a trend 
towards injecting drugs. In fact, approximately 20 to 25% of Iranian drug users have 
injected at least once in their lifetime5, and 10-15% regularly injects drugs. In 2007, it 
was estimated that 224,000 of Iranian opiate users were IDUs,11 making injection drug 
use today’s most lethal threat to the Iranian populace.5  
Significance of Focusing on Injection Drug Use 
In order to prevent and reduce the detrimental effects of injection drug use on a 
population level it is crucial to focus on identifying, and understanding the social, 
behavioral, cultural, and environmental factors that are associated with initiating injection 
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drug use. Thus, this project aimed to recognize the socio-demographic and behavioral 
characteristics that make drug users in Iran more vulnerable to initiating injection and its 
associated adverse health outcomes through assessing characteristics of injection 
initiation.  
Injecting as a route of drug administration increases the speed at which a drug 
enters the bloodstream, causing a higher likelihood of drug overdose. Narenjha and 
colleagues12 analyzed data of 3,329 substance using individuals across 29 provinces of 
Iran and found that those who used drugs intravenously were significantly more likely to 
experience a fatal overdose than those who did not inject intravenously. A recent study 
found that the most common reasons for self-poisoning deaths in Tehran, Iran were due 
to drug toxicity, opioid poisoning, and overdose resulting from injection.13 
Lack of access to clean needles has also been shown to have detrimental effects in 
Iran, as IDUs will often use a needle more than once, creating a dull needlepoint. The 
dull point can easily tear the skin and create a port for infection at the injection site. 
Previous studies have shown that the improper and repeated injection at the same site can 
result in vascular lesions, skin abscesses, and systemic infections.14, 15 
Individuals who inject are also more likely to share injection equipment including 
cottons, needles, and cookers. 50-70% of IDUs in Iran have reported a history of sharing 
injection equipment.5 Reasons for this high-risk behavior range from insufficient 
availability of clean injection equipment to fear of criminalization for requesting and 
accessing clean equipment. As a result, highly resilient viruses are spread via shared 
injection equipment. Hepatitis C virus (HCV) is the most common and causes several 
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complications including liver disease and death. Indeed, inside Iran’s prisons, HCV 
prevalence rates range from 38-90% among IDUs, who make up 40% of the prison 
population.16 
Most importantly, injection drug use and the sharing of injection equipment has a 
causal effect on the spread of HIV infection. While HIV is not as virulent as other 
infections such as HCV, it carries a much greater burden of adverse health and financial 
consequences. Estimates show that HIV prevalence is at least 22 times higher among 
people who inject drugs than for the population as a whole and, in some countries; it is at 
least 50-fold higher.17 While high-risk sexual behaviors, poverty, violence, imprisonment, 
and inadequate health care are factors that are associated with elevated HIV risk, the 
sharing of syringes by IDUs has long been identified as a central risk factor for HIV 
infection.18  
Characteristics of Injection Drug Use in Iran 
According to a study by Narenjiha and colleaugues19, the average Iranian addict is 
more likely male (95%), married (72%) and employed (72%) which is a paradox 
compared to the “low self-esteem” unemployed profile associated with drug dependence 
in many western countries. This observation may be reflecting that the socio-cultural, 
economic, and political characteristics in Iran make the drug-using populace not akin to 
the stereotypical profile of drug users. 
The implications of injection drug use plays an important role in the spread of 
HIV/AIDS in Iran as in recent years the number of HIV/AIDS cases has rapidly increased 
along with the rising prevalence of injection drug use. Estimates in 2004 indicated that 
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there were 30,000 people with HIV/AIDS in Iran20 and this number had increased to 
100,000 by 2012,17 of which only 25,041 were officially registered cases. Furthermore, 
current data indicates that in approximately 70% of registered HIV cases, the infection 
occurred through injection drug use7 and 61% of Iran’s population between ages of 15 
and 64 are currently at risk for both drug use and HIV infection.9 Other figures show that 
two-thirds of HIV infection transmission in Iran is attributed to injection drug use, and 
60% to 70% is attributed to needle sharing in IDUs,5 constituting HIV prevalence rates as 
high as 27% among IDUs.11 Previous	   studies	   also	   indicate	   the	   large	   role	   played	   by	   social	   stigma	   in	  determining	  the	  Iranian	  drug	  users’	  behavior	  in	  initiating	  injection.	  For	  example,	  it	  has	   been	   demonstrated	   that	   there	   is	   tremendous	   stigma	   attached	   to	   heroin	   or	  injection	   drug	   use,	   even-­‐though	   it	   has	   been	   common	   to	   smoke	   opium	   in	   Iran	   for	  many	  years.	   	  Furthermore,	  compared	   to	  drug	  users	   in	  other	  countries,	   Iranian	  are	  more	   likely	   to	   initiate	   using	   opiates,	   however,	   users	   are	  much	   less	   likely	   to	   both	  initiate	  and	  quit	  injection,	  with	  reports	  indicating	  average	  transition	  time	  from	  first	  drug	  use	  to	  injection	  of	  five	  years.	  	  Interestingly,	   syringes	   and	   injection	   needles	   are	   easily	   available	   in	  pharmacies	   in	   Iran	  and	  are	  made	  affordable	   through	   subsidiaries	   from	   the	  Health	  Ministry,	   allowing	   more	   than	   80%	   of	   IDUs	   to	   purchase	   sterile	   needles	   from	  pharmacies.5	  However,	   only	  half	   dispose	  of	   the	  needles	   after	   first	   use,	   almost	  half	  have	  a	  positive	  history	  of	  needle	  sharing,	  and	  at	  least	  11.8%	  claim	  to	  use	  the	  needle	  upwards	  of	  four	  times	  before	  disposal.5	  Thus,	  low	  cost,	  availability,	  and	  accessibility	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of	  clean	  needles	  may	  not	  be	  the	  only	  factors	  in	  determining	  the	  choices	  drug	  users	  make	  in	  reusing	  and	  sharing	  needles.	  Other	  factors,	  such	  as	  fear	  of	  law	  enforcement,	  arrestments,	  and	  social	  stigma	  are	  likely	  to	  play	  an	  important	  role	  in	  the	  decisions	  made	  by	  drug	  users.	   Therefore,	   these	  multiple	   influences	   on	  drug	  user’s	   behavior	  make	   Iran	   a	   special	   case	   study	   in	   which	   the	   various	   social,	   cultural,	   and	   familial	  factors	  must	  be	  assessed	  in	  relation	  to	  public	  health	  interventions	  and	  policies.21	  	  
 
Characteristics of Drug Use in Kermanshah City  
 
Figure 1: Map of Iran3   
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Figure 2: Opium Trafficking Routes1   
 
The majority of drug traffic routes occur through western Iran. As shown in figure 
1, Kermanshah City is situated on the northwestern part of Iran, and as seen in figure 2 
the drug trafficking routes passes through the northwestern part, in an area on the 
northern part of Kermanshah city. This Balkan route has two million inhabitants and runs 
through Iran to Turkey,22 facilitating the movement of opium and heroin. The route 
appears to start in Afghanistan, cuts south through western Iran, and then goes either 
north or west to Iraq. As a result, Kermanshah has one of the highest rates of heroin 
consumption in Iran. Ragghazi21 found that lifetime prevalence rates for heroin use in 
drug users in Kermanshah was 70%, 62.7% in Mashad (situated in the north-east of Iran), 
and 60% in Tehran, which is the capital city. Kermanshah also has some of the highest 
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rates in all of Iran for injection and HIV/AIDS. 21 The mean age of onset of injecting drug 
use, which has not significantly changed during the recent three decades, is mostly 
between 24 and 27 years of age. 
 
 
Characteristics of Injection Initiation 
Studies on factors that influence the transition from non-injection drug use to 
injection drug use in Iran, as reviewed by Malekinejad and colleagues11 indicates that 
there are a range of environmental, economic, individual, familial, and structural factors 
that increase the chance of moving toward or away from injection among users.23  
Individual level factors that influence crucial switching, which is defined as the 
changing to or away from opiates, or changing to or away from injection11, are age at first 
drug use, level of physical and psychological dependence, length of heroin use and 
dependence, and current use of heroin. Familial and social factors include social network 
characteristics and pressures, family history of psychological illnesses or injection drug 
use, and close relationships with other injecting drug users. Institutional or structural 
factors are access (or lack thereof) to drug treatment and history of detention since 
prisons often forbid smoking, making injection a more discreet form of drug use. 
Specific environmental reasons include the increasing ease of obtaining and using 
heroin, level of ease in hiding injection paraphernalia, market availability of the more 
pure form of opium and cost. These factors are often influenced by social, economic, and 
geo-political changes, which are important to be considered. 
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Previous studies suggest a pathway of crucial switching in Iran: which begins 
with smoking opium and progresses to smoking Shireh, sniffing heroin, smoking heroin, 
and finally injecting heroin.11 Malekinejad and Vazirian11 suggest that by identifying the 
factors that facilitate this transition, one gains the ability to target the factors in order to 
provide more effective harm reduction opportunities. Therefore, it is important to 
consider the geo-political changes that affect drug use behavior. For example, supply 
reduction efforts by the Taliban in Afghanistan in 2000-2001 effectively reduced the 
availability of opium in Iran up until the U.S. led invasion of Afghanistan in 2001.24 
Some have considered this transition as the strongest historical impact on opium and 
heroin supply in modern days as there was a 99% reduction in the area of opium poppy 
farming in Taliban-controlled areas and, globally, there was an estimated 65% reduction 
in the potential illicit heroin supply from harvests in 2001.25  
The ban left thousands of small farmers and share croppers without income and 
created an immediate spike in the price of opium at the Afghanistan’s border from its all-
time low of $28 per kilo to almost $400 according to UNODC and the DEA.26 Farmers 
were heavily indebted for their farm loans, economic pressures and poverty spread 
throughout the area, and opium became prohibitively expensive. Users who were once 
easily able to maintain a certain level of drug tolerance now had to inject in order to 
satisfy their level of craving with the same cost. Injecting, as Malekinejad and Vazirian11 
point out, was more effective than smoking or inhaling to reach this “fix” and led to a 
crucial switching. Hence, the unintended consequences of reduced availability led to the 
switch to injection of drugs for cost utilization and tolerance reasons.  
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 Exploring and understanding the depth and varieties of drug use for the Iranian 
population is significant not only for public health but also Iranian national security. 
Illicit export, import, and general drug trade in Iran has led to money laundering and 
corruption, creating a serious obstacle to development.7 Historically, there have been 
significant efforts by the UNODC, its partner non-profits, and community-based 
organizations for harm reduction measures of drug use.7 However, increasingly pervasive 
opiate use has resulted in a need for a better understanding of the associated risk factors 
and behaviors of IDUs and NIDUs. 
The aim of this study is to identify and compare the socio-demographic statuses 
and behavioral factors of injecting and non-injecting drug users in the western part of 
Iran. This study will contribute by building the profile of IDU and NIDUs in Iran and 
providing insight into risk factors promoting drug-seeking behavior. Indeed, there is 
starkly insufficient literature on risk factors related to onset of injection drug among drug 
users in Iran, especially pertaining to quantitative data. By providing data and identifying 
salient risk factors, this work will help guide harm reduction policies to prevent the 
transition to injection amongst high-risk non-injecting opioid users prone to injecting 
drugs in the future. This work will have implications for prevention, treatment, and policy 
measures. If successful, reduction in injection drug use will lead to better control of the 
transmission of viruses associated with IDUs such as HIV and HCV infection. In respect 
to prevention, by studying the factors in Iran that significantly influence NIDUs and 
make them more vulnerable to becoming IDUs, we can design new interventions to 
reduce the likelihood of injection amongst all drug users. In regards to treatment, early 
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treatment of drug users who have greater risk for injection in near future can have a 
reduced or postponed chance of transition to injection.  For policy implications, this study 
can critique the existing drug policies in Iran which provide hard reduction services only 
for injection drug users. It can recommend policy makers to offer harm reduction 
programs to those who have yet to inject and are at greater risk for injection given certain 
factors explored in this study. 
 
Theoretical Framework for Factors Affecting Drug Use  
Multiple facets of physical and social environments interact at various levels and 
influence health. The socio-ecologic model of health outcomes has five different levels; 
intrapersonal, interpersonal, institutional, community and policy factors. 27 Various levels 
of the ecologic model can influence the exposure to drugs differently. This study focuses 
on the first two levels; the intrapersonal and interpersonal levels. It is essential to improve 
our knowledge with respect to the transition from non-injection to injection drug use by 
looking at different frameworks that integrate risk factors into a theoretically more 
meaningful perspective, given that the transition to injection is influenced by both 
personal and social factors.28 Figure 3 demonstrates the theoretical framework, which 
was considered in this study to assess what personal and social factors may motivate 
some drug users to initiate injection. 
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Figure 3: Theoretical Framework for Factors Affecting Drug Use  
Risk factors are the experiences and characteristics that increase the likelihood of 
dependence and other outcomes such as injection initiation and exposure to HIV/AIDS, 
whereas protective factors are those that decrease this chance. There are important factors 
at the individual, peer, family and community level that predict for or protect against 
injection. Prevention programs targeting both risk reduction and developing protective 
factors at each of these levels are more likely to decrease the chance of initial injection.29 
As discussed, IDU and NIDU behaviors can be influenced by socio-demographic, 
behavioral and environmental factors. In regards to socio-demographic factors they can 
be designated as gender, age, education, marital status, job status, housing status, 
smoking status, dependency status, location, and income. 
Injection 
Initiation Risk 
Factors 
Personal 
Factors 
Demographics                       
(gender,age, and place of birth ) 
Drug Use History              
(age of initiation, first type, 
current type and method of use, 
frequency and quantity, money 
spent , needle sharing) 
History of 
Rehabilitation (reason for 
seeking treatment, history of 
rehabilitation, frequency, 
location and longest period of 
rehabilitation) 
Other Predisposing 
factors (current status and 
history of smoking, age of 
smoking initiation). 
Social Factors 
Social Marginalization 
(level of education, marital 
status, number of children, job 
status, housing status, and total 
monthly income)	  
Personal Networks          
(family history of addiction, 
who offered it first, location of 
initiation)	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Given the aforementioned theoretical framework, different studies focusing on 
risk factors for injection initiation between injection and non-injection drug users are 
described in the following section classified in two main categories; personal factors and 
social factors.  
Personal related risk factors include four main domains: Demographics (gender, 
age, and place of birth); Drug use history (age of drug use initiation, first type of drug 
use, current type and method of drug use, frequency and quantity of use, average amount 
of money spent on purchasing drugs, and history of needle sharing); History of 
rehabilitation (reason for seeking help from the addiction clinic, history of rehabilitation, 
frequency, location and longest period of rehabilitation); and other predisposing factors 
(current status and history of smoking, and age of smoking initiation). 
Social related risk factors include two main domains: Social marginalization (level of 
education, marital status, number of children, job status, housing status, and total monthly 
income); and Personal networks (family history of addiction, who offered it first, and 
location of initiation);  
Significance of this Study 
The specific aim of this study is to develop a greater understanding of the key 
factors that make drug users in the western part of Iran more or less vulnerable to initiate 
injecting drugs, based on the presented theoretical framework. Therefore, the analysis 
compares the profile of IDUs and NIDUs in order to elucidate the significant risk factors 
that could be a target for harm-reduction interventions. The results are particularly 
insightful since to-date only a handful of studies have assessed the factors associated with 
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initiating injection among drug users in Iran. Moreover, there is a significant lack of 
quantitative data available on injection drug use in Iran, which limits the possibility for 
any conclusive evidence.  
Previously, two published studies examined the transition to injection drug use. In 
the first one, researchers interviewed 154 IDUs in six districts of Tehran.5 This study only 
measured the risk factors among IDUs without assessing their impact on injection 
initiation by NIDUs. In the second study,30 60 IDUs were compared with 60 NIDUs in 
Tehran on each group’s risk for injection initiation. The findings of this study cannot be 
generalized, since the control study subjects were selected based on their friendship with 
IDUs, and were therefore not a representative sample of the population that gave rise to 
the cases. Certain factors such as demographic variables; age, sex, source of income, and 
literacy level and other variables; onset age of cigarette smoking, dropping out of school, 
imprisonment, history of sexual relationship for money, and family history of using 
illegal drugs were studied. Thus, these studies could be expanded to include other 
variables such as details of drug history, personal networks, and social marginalization, 
which have been included in this analysis.  
According to the aforementioned theoretical framework, this current study 
examines personal and social predictor risk factors for injection initiation between 
injection and non-injection drug users by evaluating a set of independent variables 
integrated into six main domains: Demographics (age, gender, place of birth and current 
residence); Drug use history (age of drug use initiation, first type of drug use, current 
type and method of drug use, frequency and quantity of use, average amount of money 
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spent on purchasing drugs, and history of needle sharing); History of rehabilitation 
(reason for seeking help from the addiction clinic, history of rehabilitation, frequency, 
and location and longest period of rehabilitation); Other personal predisposing factors 
(current status and history of smoking, and age of smoking initiation); Social 
marginalization (marital status, number of children, job status, level of education, 
housing condition, and total monthly income); and Personal networks (who offered it 
first, location of initiation, and family history of addiction).  
Moreover, the sample size of this study is significantly larger compared to the two 
previous studies, and cases and controls were selected randomly, independent of health 
outcome, and without considering relationship or friendship. Finally, there were only two 
methadone clinics in the entire province of Kermanshah. The clinic that the subjects 
attended was the primary treatment facility and subjects came from all around the 
province. Thus, another strength of this analysis is that the results are more generalizable 
to the majority of the male drug using population in Kermanshah, which includes 5% of 
the two million inhabitants of this province.  
Most importantly, since the environmental and geopolitical context of the 
assessed factors may change over time it is important to assess time trends in drug use 
behavior and choice. Thus, one of the strengths of this analysis is that it considers the 
differences in the factors that are associated with injection initiation, depending on the 
subjects’ date of drug use initiation. In particular, it was thought that the impact of 
predicting risk factors for injection initiation may be considerably different based on the 
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onset of drug use being before or after the ban on poppy seed production in Afghanistan, 
which occurred in 2000. 
By collecting data and identifying salient risk factors, this work will help guide 
harm reduction policies to prevent the transition to injection amongst high-risk non-
injecting opioid users prone to injecting drugs in the future. This work will have 
implications for prevention, treatment, and policy measures. If successful, reduction in 
injection drug use will lead to better control of the transmission of viruses associated with 
IDUs such as HIV and HCV infection. In respect to prevention, by studying the factors in 
Iran that significantly influence NIDUs and make them more vulnerable to becoming 
IDUs, we can design new interventions to reduce the likelihood of injection amongst all 
drug users. In regards to treatment, early treatment of drug users who have greater risk 
for injection in near future can have a reduced or postponed chance of transition to 
injection. For policy implications, this study can critique the existing drug policies in 
Iran, which provide hard reduction services only for injection drug users. It recommends 
that policy makers offer harm reduction programs to those who have yet to inject and are 
at greater risk for injection, given certain factors explored in this study. 
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METHODS 
Study Population 
 This study was designed as an observational study of drug users who sought 
addiction treatment at a methadone clinic in Kermanshah city in western Iran. The data 
analysis was a case comparison which compared IDUs to NIDs. The case patients were 
those who, either currently or in the past, used drugs by injection. The controls were drug 
users with no history of injection drug use, seeking treatment at the same clinic. Between 
February 1, 2004 and August 31, 2005, 1081 individuals, who were admitted for inpatient 
treatment agreed to participate in the study. The volunteers were verbally informed about 
the objectives of the study, confidentiality, and the required information to be collected 
from the participants. They then provided written consents to participate. The 
institutional review board of Pars Institute for Addiction Care and Rehabilitation 
approved the study.  
Of the 1081 participants, 1055 were men (97.6%), thus due to the sparse number 
of female subjects, the study was focused on the male population. After excluding the 26 
women and 107 subjects who did not indicate the outcome of ever being an injection 
drug user, 948 males were included in the final analysis.  
Data Collection 
The study questionnaire was a standard survey produced by the National Welfare 
Organization of Iran. The questionnaire was in the native language of Farsi, which is 
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translated to English and attached to this appendix. Interviewers were native Farsi 
speakers and were trained to gather information in a standardized manner. After receiving 
informed consent, the patients were interviewed in a private setting for a 30-40 minute 
risk factor survey, consisting of 30 items collecting information on age (as age at time of 
interview), gender (male, female), place of birth, place of residency (including name of 
city or village), marital status (single, married, abandonment, divorce, widow, temporary, 
etc.), number of children, job status, level of education (illiterate, able to read and write, 
elementary school, junior school, high school/diploma, associates degree, bachelor, 
master, doctorate, religions studies, others), housing condition (owner, rental, living in 
father's house, living in father in law house, residential house, or others), average 
monthly income, reason for seeking help from the addiction clinic (physical side effects 
of drugs, psychological side effects of drugs, financial problems, legal problems, 
pregnancy, family/ friend pressure, social problems, otherwise give its name), current 
status and history of smoking cigarette/tobacco, age of its smoking initiation (less than 10 
years old, then categorized with five years intervals until age 45 old, and age greater than 
45 years old), age of drug use initiation (age at time of first time use drug or alcohol), 
first type of drug use (marijuana, opium sap, opium, heroin, alcohol, otherwise name it), 
who offered it for the first time (a family member, a relative, school friends, outside 
school friends or work colleagues, strangers, if someone else name it), location of drug 
use initiation (at a family’s party, at a friend’s party, at park, at school, in the street, in 
military, at office), family history of addiction (spouse/partner, father, mother, brother, 
sister, child), current type and method of drug use (smoking, swallowing, injection, 
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drinking, enema, snorting) they could select more than one option, frequency and 
quantity of drug use per day, average amount of money spent on purchasing drugs, 
history of needle sharing, history of rehabilitation, frequency, location and longest period 
of rehabilitation. The dependent variable was the outcome of injection drug use 
experience. Current drug use was defined as using drug on at least 1 day during the 30 
days before the survey.   
Statistical Analysis 
 Univariate analysis was conducted to describe the study sample's demographics, 
life experience, family history and drug use behaviors. Logistic regression was employed 
to assess both unadjusted and independent effects of potential risk factors. All variables at 
(P< or = 0.1 were included in the multivariate logistic-regression analysis. Interaction 
terms were systematically tested. In SAS a logistic regression process with stepwise, 
backward, and forward selection was respectively employed to arrive at the final 
parsimonious model.  
 In 2000, there was a significant rise in the regulations of drug trafficking by the 
government of Iran and bans were placed in Afghanistan on growing poppy. It is believed 
that these policy changes would significantly alter the behavior and drug of choice of the 
research subjects after 2000.  Thus, the population was stratified with respect to the onset 
date of drug use as before and after 2000, Staratum specific univariate and multivariate 
analysis was performed and the point estimates were observed to be markedly different, 
however the confidence intervals overlapped. Hence, to assess the significance of 
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interaction and effect measure modification a multivariate logistic regression analysis 
was performed on the total population, which included the interaction of first drug choice 
with onset of addiction. The interaction terms did not meet the 0.5 significance level and 
were then omitted from the model. All data were analyzed with the Statistical Analysis 
System (SAS Institute, Version 9.3, Cary, N.C.).  
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RESULTS 
Crude Analysis 
The study population included 177 cases of injection drug use (18.67% of the 
total population), and 771 controls with no history of injection drug use. The mean age 
was 4.5 years younger among cases (32.5 versus 37 years) and the mean age for the onset 
of drug use was 2.5 years younger among the cases (22 versus 24.5 years). Consequently, 
the mean length of the addiction period was lower among the injection drug users by 
almost 2.5 years. The differences in current age, onset age of drug use, and length of 
addiction were all statistically significant at P<0.001.  
Most of the study population had an urban residence and birthplace; however a 
significantly higher proportion of cases were born and lived in urban areas. More than 
half of injection drug users had completed high school or beyond and the proportion was 
significantly higher in comparison to controls (53.6% versus 44.6%). On the other hand, 
a significantly higher proportion of cases (26% of cases versus 17.6% of controls) were 
unemployed, single (41% of cases versus 21.9% of controls) and never had children 
(52.5% of cases versus 30.5% of controls). Thus, overall, unemployed subjects who, had 
at least a high school diploma, were born and lived in urban areas, were never married, 
and never had children, had higher odds of initiating injection drug use. (Table 1) 
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Table 1: Injection Initiation Risk Factors 
Injection Initiation Risk Factors 
Risk Factor Injecting Users       Non-Injecting Users Crude  Odds Ratio     
(95% CI) 
P-Value 
Personal  Fac tors  
Demographics 
Mean Age (SD)  32.5 (8.13) 37.1 (9.28) N/A <0.0001 
Place of Birth %Urban  92% (N=177) 86.5% (N=771) 1.8 (1.1, 3.3) < 0.05 
Residence %Urban  97% (N=177) 93% (N=771) 2.4 (0.9, 6.0) 0.06 
Drug Use Characteristics 
Frequency: >4 times per day 36% (N=177) 19.7%(N=771) 2.3 (1.6, 3.3) <0.0001 
Expenditure: Highest quartile 57% (N=177) 49.9%(N=771) 1.4 (1.0, 1.9) 0.06 
First Drug:  
     Opium 
     Opium SAP 
     Marijuana 
     Buprenorphine 
     Heroin 
     Alcohol 
47% (N=177) 78% (N=771) 0.3 (0.24, 0.47) <0.0001 
7.6% (N=177) 13.7% (N=771) 0.5 (0.27, 0.9 ) <0.05 
11% (N=177) 5.1% (N=771) 2.3 (1.3, 4.01) <0.01 
20% (N=177) 0.4% (N=771) 62  (18.9, 205) <0.0001 
15% (N=177) 5.8% (N=771) 2.8 (1.7, 4.7) <0.0001 
12.99% (N=177) 12.32% (N=771) 2.64 (0.63, 11.16) 0.16 
Current Drug:  
     Opium 
     Opium SAP 
     Marijuana 
     Buprenorphine 
     Heroin 
     Alcohol 
30% (N=177) 75.6%(N=771) 0.15 (0.1, 0.2) <0.0001 
13.1% (N=177) 25.5%(N=771) 0.45 (0.3, 0.73) <0.001 
4.4% (N=177) 1.4%(N=771) 3.13 (1.24, 7.9) <0.05 
32.8% (N=177) 0.8%(N=771) 61.7 (26.1, 146) <0.0001 
24%	  (N=177)	   9.7%(N=771) 2.96 (1.95, 4.48) <0.0001 
1.69% (N=177) 0.65%(N=771) 1.05 (0.65, 1.73) 0.8 
History of Rehabilitation 
History of seeking rehabilitation 62.2% (N=177) 62.9% (N=771) 0.96 (0.69, 1.36) 0.85 
Method of Attempting to Quit:     
     Individually  
     Outpatient Private Center 
     Law Enforcement Camp 
68.4% (N=177) 71.7% (N=771) 0.85 (0.6, 1.22) 0.37 
4.0% (N=177) 3.2% (N=771) 1.2 (0.5, 2.9) 0.63 
6.2% (N=177) 1.2% (N=771) 5.6 (2.3, 13.8) <0.0001 
Frequency of quitting: >once 7.3% (N=177) 8.3% (N=771) 0.88 (0.47, 1.63) 0.67 
Reason for seeking treatment:  
     Financial Issues 
     Psychological Issues 
     Social Issues 
     Family Issues 
59.9% (N=177) 59.7% (N=771) 1.0 (0.72, 1.4) 0.96 
57.63% (N=177) 53.83% (N=771) 1.2 (0.83, 1.62) 0.36 
22.0% (N=177) 24.7% (N=771) 0.85 (0.58, 1.27) 0.44 
1.7% (N=177) 14.4% (N=771) 0.71 (0.43, 1.2) 0.2 
Other predisposing factors 
Smoking 87.6% (N=177) 88.5% (N=771) 0.92 (0.56, 1.52) 0.74 
Smoking age initiation below 20 57.1% (N=161) 44.3% (N=600) 1.7 (1.2, 2.4) <0.01 
Soc ia l  Fac tors  
Personal Network 
Who offered first:      
     Relative 
     Friends from school 
     Friends outside of school 
20% (N=177) 19.8% (N=771) 1.0 (0.8, 1.8) 0.95 
4.6% (N=177) 4.8% (N=771) 0.98 (0.8, 1.6) 0.95 
52.41% (N=177) 53.46% (N=771) 0.92 (0.9, 1.3) 0.96 
Location of initiation:      
     Friend’s Parties 
     Street 
61.2% (N=177)  61.4% (N=771) 0.98 (0.8, 1.6) 0.95 
8.74% 5.10% 1.8 (1.0, 3.3) 0.06 
Family History 31.6% (N=168) 21.9% (N=752) 1.6 (1.1, 2.4) <0.01 
     Father Addict 
     Brother Addict 
12.4% (N=177) 8.8% (N=771) 1.5 (0.88, 2.44) 0.13 
14.1% (N=177) 10.5% (N=771) 1.4 (0.86, 2.27) 0.16 
Social Marginalization 
Marital Status 41% (N=167) 21.9% (N=751) 2.5 (1.8, 3.6) <0.0001 
Number of children: 0 52.5% (N=177) 30.5% (N=771) 2.5 (1.8, 3.5) <0.0001 
Education: High school or 
higher  
53.6% (N=177) 44.6% (N=771) 1.4 (1.1, 2.0) <0.05 
Job Status: Unemployed  26% (N=177) 17.6% (N=771) 1.6 (1.1, 2.4) <0.05 
Monthly Income in TM 151921 (N=163) 149820 (N=570) N/A 0.93 
Housing Status: Dependent 20.3% (N=177) 15.6% (N=771) 1.39 (0.91, 2.09) 0.12 
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Living arrangement was also analyzed by looking at those who were independent 
(either owned or rented their own house) compared to those who were dependent on 
family, friends, or residential facilities. There was not a significant difference seen and 
most (80% of cases and 84% of controls) lived independently by either owning or renting 
their own house. 
A significantly higher proportion of cases had at least one person in the family 
who used drugs (31.6% of cases versus 21.9% of controls). Yet, even with a higher 
family history of drug use among the cases, when asked who gave the subjects drug for 
the first time, most indicated friends and coworkers as opposed to family members. 
However, there was not a significant difference on who first gave drugs to the cases 
versus controls. A significantly higher proportion of cases indicated that they initiated 
drug use on the streets (8.7 % of cases versus 5% of controls), and that they started 
smoking before reaching the age of 20 (57 % of cases versus 44% of controls). (Table 1)  
Current patterns of drug use indicate that cases used drugs more frequently than 
controls. A significantly higher portion of cases indicated that their drug use frequency 
exceeded four times per day (36% of the cases versus 19.7% of controls), which was the 
highest response category in the survey. Furthermore, the injection drug users were more 
likely to spend more money on drugs and in the highest expenditure category (57% of 
cases versus 49.9% of controls). (Table 1) 
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Overall there was not a significant difference among the cases and controls on 
quitting history. 63% of both cases and controls tried to quit at least once in their history 
of drug use. They also reported trying to quit individually more than any other method, 
followed by attending a private clinic. However, a significantly higher proportion of 
injection drug users (6.2% of the cases versus 1.17% of controls) quit in prisons or 
government camps. (Table 1) 
When asked about the reason for visiting the methadone clinic, most subjects 
indicated financial problems as the main reason for seeking help, followed by choosing 
social pressure, psychological side effects of the drug, and familial pressure. However, 
there was not a statistically significant difference on the reason for seeking help among 
the cases and controls.  
The odds of initiating injection was significantly higher among those who began 
using drugs with buprenorphine (OR: 62), heroin (OR: 2.8), or marijuana (OR: 2.3), 
respectively. Opium and opium sap had protective effects against injection initiation and 
the odds were 70 % lower among those who initiated drug use with opium (OR: 0.3) and 
50% lower with opium sap (OR: 0.5). (Table 1) Looking at current type of drug use, a 
similar association was seen. (Table 1) Similarly, the association with types of drugs used 
within history of drug use was assessed, and the results were not significantly different 
from first or current drug of choice (data not shown).  
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Adjusted Analysis 
The final logistic regression model identified 4 factors that were associated with 
injection initiation. Younger age, drug use initiation with buprenorphine (OR=15.7), drug 
use frequency of four or more times per day (OR=3.1), and history of quitting in 
government camps (OR=3.8) remained in the model after backward, forward, and step 
wise selection with p-values ranging from P=0.033 to P<0.0001. (Table 2)  
Table 2: Adjusted Measures of Association 
Logistic Regression Analysis  
 
Risk Factor 
Crude Odds Ratio 
(95% CI) 
 
P-Value 
Initiated Drug Use with Buprenorphine 15.7 (3.3, 56)   0.0015 
Drug Use Exceeded 4 Times per Day 3.1 (1.5, 4.8) <0.0001 
Prior Quitting in Government Camps 5.8 (1.5, 22.5)    0.033 
 
The Impact of the Ban on Poppy Seed Production in Afghanistan 
Buprenorphine was strongly associated as an initiation drug, both in the crude and 
adjusted measures. Furthermore, in 2000, there was a significant rise in the regulations of 
drug trafficking by the government of Iran and bans placed in Afghanistan on growing 
poppy, which formed the basis for the hypothesis that the choice of drug type and 
behavior of subjects could have changed after 2000. Thus, the population was stratified 
based on the onset of drug use and the crude measures of effect were assessed. 
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Table 3: Drug Choices Before and After 2000 
Analysis of Drug Use Based on Initiation Date 
Drug Choice Crude Odds Ratio                
(95% CI) 
P Value 
Cases of IDU (N=74/488) who initiated Drug Use Prior to 2000,  
First Drug Opium  0.47 (0.28, 0.8)   <0.01 
First Drug Buprenorphine 12.4 (3.4, 42.6) <0.0001 
                Cases  of IDU (N=26/122) who initiated Drug Use After 2000  
First Drug Opium  0.26 (0.17, 0.42) <0.0001 
First Drug Buprenorphine 57 (13.2, 245) <0.0001 
 
Table 4: Adjusted Measures of Association Before and After 2000 
 
Logistic Regression Before and After 2000  
Risk Factor Point Estimate P-Value 
Cases who initiated Drug Use Prior to 2000 
Initiated Drug Use with Buprenorphine 13.6 (3.3, 55.5) 0.0003 
Prior Quitting in Law Enforced Camps 5.7 (1.45, 22.5) 0.0129 
Drug Use Exceeded 4 Times per Day 2.7 (1.48, 4.8) 0.0011 
Cases who initiated Drug Use After 2000 
Initiated Drug Use with Buprenorphine 32 (2.3, 444) 0.0099 
Obtained High School Diploma or Higher 7.5 (1.5, 37.5) 0.014 
Drug Use Exceeded 4 Times per Day 4.7 (1.3, 16.6) 0.0164 
 
Both the crude and adjusted measures of initiating drug use with buprenorphine as 
associated with injection initiation were markedly higher among those who began drug 
use after 2000 (crude OR: 57, adjusted OR: 32) versus those who began drug use prior to 
2000 (crude OR: 12.4, adjusted OR: 13.6), indicating a change in drug choice after 2000. 
Moreover, the protective association of opium was considerably lower among those who 
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began using drugs after 2000 (crude OR: 0.47) versus those who began drug use prior to 
2000 (crude OR: 0.26). 
Interestingly, the association between obtaining at least a high school diploma and 
injection initiation appeared in the final logistic regression model (adjusted OR: 7.5) 
among those who initiated drug use after 2000. However, this association did not remain 
in the final model, which assessed the group who began drug use prior to 2000. On the 
other hand, among the group who first used drugs prior to 2000, attempts to quit at 
prisons or government camps had a significant association with injection initiation (OR: 
5.7). (Table 4)  
These results indicate that the measures of effect are considerably different based 
on the onset of drug use being before or after 2000. This is classic effect measure 
modification based on date of drug use onset. Tables 3 and 4 indicate the crude and 
adjusted measures respectively. This supports the hypothesis that choice of drug and 
behavioral of the drug users changed after 2000.  
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DISCUSSION 
 	   This study revealed statistically significant associations between social and 
personal factors and injection drug use. After adjusting for confounding factors through 
logistic regression analysis, the statistically significant factors that were observed to be 
associated with initiating injection were young age, buprenorphine use, high daily 
frequency of drug use, and history of imprisonment. Moreover, this study looked at time 
trends in changes of drug users’ behavior and choices of drug based on the date of the 
ban on poppy seed production in 2000 by the government of Afghanistan. Interestingly, 
we found that the subjects that initiated drug use after the year 2000 were more likely to 
be educated, with at least a high school diploma or higher, whereas those who initiated 
injection prior to 2000 were more likely to have been imprisoned and had attempted to 
quit drug use in law enforced camps.  
Additionally, this study looked into the trends in drug choice and attempted to 
understand the significant associations with the choice of initial drug use experience and 
subsequent switch to injection drug use. Previous international studies have looked into 
the associations in drug use trend and injection drug use experience but few were 
performed in Iran. However, due to cultural and drug market differences in countries it is 
vital to study these trends in a country specific manner. For instance, while the use of 
methamphetamines in the USA is extremely common among drug users31, in Estonia, this 
is not the case, and fentanyl is much more popular among drug users.32 In Iran, opium 
plays the largest role in drug use.10 To date, this is the first attempt to look into the drug 
choice trends in Iran. 
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A significant proportion of all drug users are more vulnerable to intravenous drug 
use compared to other drug users. There are a few prominent risk factors that may raise 
this group’s risk for intravenous drug use. Some of these factors are demographic which 
cannot be changed easily. The rest are rooted in behavior and are more feasible points of 
intervention. According to the theoretical framework considered in this study, injection 
initiation is influenced by both personal and social factors, in addition to the interaction 
of all those factors. In this study we assessed risk factors that had an association with 
injection with respect to these two main categories; personal and social factors which 
may have encouraged injection drug use in previously non- injection drug use groups to 
initiate injection. Since the majority of drug users in Iran and in this study are male, we 
focused on male drug users in our data analysis. However, this is a major limitation as the 
results of the study are not generalizable to women, especially since the reason for the 
low estimate of women drug users in Iran could be attributed to women addicts not 
seeking any treatment due to fear of stigma and marginalization, rather than a truly low 
prevalence of drug use among women.  
Our crude analysis of the personal factors that have an impact on injection 
initiation indicated that drug users who were younger, and were born or lived in an urban 
area were more likely to be among drug users who switched to injection. These factors 
fall in the category of demographic factors within our theoretical framework, and are 
much less feasible points of intervention.  
Additional analysis of the personal factors indicated that drug users who started 
smoking before the age of 20 and used drugs four times or more per day, were more 
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likely to start intravenous drug use than those who did not have any of these risk factors. 
These factors are could be a target of public health interventions and modulated through 
policy changes to have a better outcome and a more positive health impact. 
Studying the trends in drug choice and usage practices indicated that subjects 
either initiated, or at some time-point experienced using drugs such as buprenorphine, 
heroin, or marijuana were more likely to initiate intravenous drug use than those who had 
none of these risk factors. Opium and Shire usage were found to have protective effects 
against the initiation of intravenous drug use. These findings, which fall within the 
category of drug use history in our theoretical framework, could be considered as 
behavioral factors that are highly influenced by cultural norms of drug use, showing that 
Opium use has a protective effect against switching to injection drug use.  
Among social factors, drug users who obtained more education, were 
unemployed, single or who had never had children were more likely to initiate 
intravenous drug use in comparison to those who did not fit any of these risk categories, 
representing the impact of social marginalization on injection initiation, which is included 
in our theoretical framework. Also, subjects who had attempted to cease drug use in 
prisons or law-enforced camps, and those who had at least one blood relative who was 
also a drug user, were more likely to start intravenous drug use, which is evidence for the 
impact of personal network on injection initiation in our theoretical framework. 
Looking at the independent effect of the assessed factors, after adjusting for 
confounding effects through a multiple logistic regression analysis, revealed that the only 
personal factors that remained significantly associated with an increased odds of 
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initiating intravenous drug use included younger age, buprenorphine use, using drugs 
four times or more per day, and history of drug use cessation in prison or government 
camps. To our surprise after adjusting for interactions and confounding factors, none of 
the social factors such as the impact of social marginalization and personal networks 
remained in the model after logistic regression analysis. 
Younger age was the only significant risk factor among demographic risk factors 
that influenced a drug user’s likelihood of switching to intravenous drug use, after 
adjusting for multiple factors. The impact of age in this study is similar to the effect of 
age in other studies such as Cheng in 200633, and Sanchez in 200634. In a study conducted 
by Roy in 2003, individuals younger than 18 years of age in Montreal are a population at 
risk to initiate injection.35 These findings emphasize the importance of health education 
and public health preventative intervention campaigns to target youth in order to prevent 
this young population from switching to injection, and prevent them from becoming a 
candidate for the detrimental health outcomes associated with injection. 
Before the Iranian Islamic Revolution, from 1974 to 1977, a detoxification 
program was implemented throughout Iran, serving approximately thirty thousand drug 
users through effective rehabilitation centers and public health educational campaigns.36 
However, after the revolution of 1979 drug use was made illegal and compulsory 
‘rehabilitation’ camps replaced the treatment centers, imprisoning drug users as 
criminals. The arrested users were then forced to quit drug use in jails, where no 
treatment was provided and the laws against dealing or using drugs were strictly 
enforced. Throughout the 1980s and 1990s, thousands of drug users were arrested by 
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courts and were sent to government enforced treatment or rehabilitation centers or 
prisons.37 However, since there were no medical facilities inside the prisons for 
detoxification and rehabilitation, the prisoners were put at a greater risk for initiating 
intravenous drug use and sharing of needles.  
Studies of specific districts in Tehran indicate that individuals are more likely to 
inject heroin in private locations, which have an easy accessibility to heroin.38 However, 
our findings demonstrated that people who quit their addiction in prison or government 
camps were at higher risk to initiate injection compared to those who quit outside prison 
after controlling for other confounding factors.	  It shows that these uncompromising law 
enforcement measures had contradictory outcomes. Instead of helping drug users to curb 
their addiction, these laws put users in a condition to shift to injection since they lack 
access to counseling services inside these camps and have limited access to 
supplementary therapy or non-injecting methods of using drugs. 
High frequency of drug use per day was another risk factor that was found in our 
analysis to be significantly associated with initiating injection drug use. Prior studies 
showed little association between frequency of drug use and transition of non-injection to 
injection drug use. For instance, Sanchez and his colleagues did not find any statistically 
significant differences between recently transitioned injection drug users (IDUs) and 
sniffers when looking at the risk factor of using more than 3 times a day.34 However, 
according to another study conducted by Cheng and her colleagues, injection 
drug use was associated with greater frequency of Methamphetamine use.39 
Interestingly, we found this factor to be a risk factor for injection initiation. Drug users 
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with high frequency of drug use (four times or more per day) were at greater risk for 
initiation of injection compared to other drug users. This is a measure of dependence 
which means that drug users who use drugs more frequently on a daily basis are more 
dependent on drugs so they are more likely to be at risk for injection initiation. 
In contrast to other studies, the impact of other risk factors to initiate intravenous 
drug use such as place of birth, neighborhood of residence, education, employment, 
marital status, having children, cost of drugs or place of drug use was not associated with 
initiating injection in a statistically significant manner after adjusting for confounding 
and other factors as these factors were initially included into the logistic regression model 
but were dropped due to statistical non-significance. Moreover, the age in which subjects 
started smoking or a family history of drug use was not associated with injection 
initiation after adjustment for other factors. 
Analyzing the association of first drug used and subsequent choices in drug use 
elucidated that compared to opium, buprenorphine as the first drug used by subjects 
increased the odds of injection as it seems to be a significant gateway drug for the 
transition to intravenous drug use. Opium, in contrast, was found to be negatively 
associated with the transition to intravenous drug use. Another similar study of 
adolescents in Canada conducted in 2003 by Roy and colleagues showed that those who 
had used hallucinogens, solvents, glue, tranquilizers, cocaine, crack, freebase, 
amphetamines, or partook in poly-drug use in the last month were twice as likely to 
initiate injection compared to those who had not taken the aforementioned drugs.35 In 
1996 another study by Crofts and colleagues, using amphetamines as a first drug of use 
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was a statistically significant characteristic of an individual’s transition to injection.40 
However, in a study in Thailand, taking heroin as the initiation drug was associated with 
a greater likelihood of transition into injection, while starting with amphetamines lowered 
the risk.33 These studies all point to the importance of first drug choice in having a 
significant impact on the odds of injection initiation. 
According to other studies conducted in Iran and other countries, environmental 
factors impacted drug choice and the odds of initiating intravenous drug use. These 
factors included the relative ease of obtaining and using heroin, reduction in availability 
and increases in the cost of opium, and the increase in the impurity of opium in 
combination with a growing heroin market. Therefore, it was of interest to look at such 
changes in the environment that may have occurred over time and impacted the choices 
and behaviors of drug users.  
In 2000, there was a significant rise in the regulations of drug trafficking by the 
government of Iran and bans were placed in Afghanistan on growing poppy. We believe 
that these policy changes would significantly alter the behavior and drug of choice of our 
research subjects after 2000.  Thus, the population was stratified based on the onset date 
of drug use being before or after the year 2000.  Crude measures of effect were then 
measured and assessed and we found that there were significant differences among 
subjects who initiated drug use before or after the year 2000. Of particular interest, 
subjects who began using drugs prior the ban on poppy had much higher odds to have 
used Buprenorphine as first drug, whereas the subjects who began drug use prior to this 
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change in the market availability of opium were more likely to begin drug use with 
opium.  
The analysis also indicated that the drug users faced many different overall risk 
factors for injection initiation. After adjusting for confounding and other factors, the 
group who began using drugs after 2000, an association was found between injection 
drug use and level of education (defined by having at least a high school diploma). 
However, this association did not remain significant in the group who began drug use 
prior to 2000.  On the other hand, drug use cessation during incarceration had a greater 
effect on the transition to intravenous drug use in the group who started using drugs 
before 2000. Therefore, being in prison or mandatory governmental camps for 
rehabilitation was a risk factor for injection among drug users who began using drugs 
prior to 2000, whereas among those who initiated using drugs after the ban on poppy in 
Afghanistan being more educated was associated with initiating injection drug use.  
One possible explanation for the association of imprisonment and injection 
initiation could be attributed to the lack of access to any substance therapy inside prison 
camps before 2002104  making drug users who were forced to quit in prison and law-
enforced camps at a greater risk for injection. After 2001, methadone therapy in addition 
to HIV/AIDS prevention and counseling was made available in the prisons of 
Kermanshah other provinces, which may be an explanation for the loss of a significant 
association with injection initiation in the population who used drugs after 2000.  
Most interestingly, higher levels of education did not seem to increase the risk of 
injection initiation for drug users who initiated using drugs prior to 2000, but was a 
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significant risk factor for those who began using drugs after the ban on poppy. Therefore, 
it is important to consider the differences in the choices available to the later more 
educated users that might have made them more prone to injection initiation.  One such 
important change in the available choices is the decreased availability of Opium and 
increased use of buprenorphine as the first line of drug. Buprenorphine use explains the 
increasing rate of injection initiation even among those who are more educated and were 
previously not likely to initiate injection. This finding clearly demonstrates that the 
behavior of drug users is highly changing based on specific environmental and 
geopolitical factors, and that it is essential to consider the time period of drug use 
initiation in public health studies and intervention campaigns. 
These findings suggest that to create and practice effective harm reduction 
strategies, policy makers and practitioners must take various time-dependent and 
environmental factors into consideration. For instance, while at a certain period of time 
the imprisonment could be a risk factor for injection initiation, changes in prison 
environments might lead to improved treatment and recovery options, thus ceasing to 
play a role in increasing the odds of injection inside such environments. On the other 
hand, when observing an increasing trend of injection drug use among the more educated 
sector of the population, one must look closely into the changes in the environment that 
might have produced such a new detrimental effect.  
Harm reduction policies must be dynamic and appropriate for the time period of 
interventions. Medical and public health professionals must be able to cater their care of 
drug users based on certain indirect factors that may have impacted risk of injection 
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initiation in each new generation of at risk populations. Factors such as date of addiction 
initiation may not directly affect the risk of injection initiation; however, knowledge 
about these factors can indirectly guide us to identify and assess other contextual factors 
which may have an impact on the significance of risk factors that could lead to injection 
initiation.  
This is most important in a country like Iran, with an unstable and constantly 
changing economy and geopolitical situation. Public health interventionists must always 
be aware of the implications of such time-dependent pressures on the population, and it is 
crucial to continually study the changes in drug user behavior in relation to the constantly 
changing geo-political, economic, social, and environmental factors. 
In conclusion, caution must be applied to not group drug using populations into 
broad categories, as we must consider many contextual, social, cultural, political, 
economic, and environmental, factors into policy designs, intervention implications, and 
treatment strategies. Furthermore, it is important to consider these factors in a time-
dependent manner by taking previously ignored factors, such as date of drug use 
initiation into consideration and continually monitor, modify, and adapt our strategies in 
accordance with changing environments.  
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Applications and Policy Implications of this Study 
Identifying the risk factors for injection initiation can help us to design more 
effective strategies to prevent NIDUs from becoming IDUs by providing harm reduction 
services to those who have yet to inject and are at greatest risk for injection.11 Since most 
heroin injectors in Iran have a history of several years of smoking opium or heroin before 
transitioning to injection, health authorities should be encouraged to implement harm 
reduction policy on a societal level via solutions such as educational programs targeting 
young, high-risk NIDUs and their family members. Efforts to reduce the possibility of 
injection initiation should include successful solutions from other countries such as oral 
substitution treatments, provision of non-injecting equipment, and provision of safe 
smoking facilities. Specifically, interventions must encourage injection drug users to quit 
drug use, improve methadone maintenance therapy (MMT) and other substance therapies 
(OSTs), and/or switch to relatively safer mode of drug use.5 
Drug users need to be able to access and understand provided information about 
harm reduction in order to help them to use adequate prevention methods before their 
exposure to risky behaviors. Limited health literacy on risk of injection causes drug users 
to fail to obtain or understand important information regarding injection, prevention and 
harm reduction techniques. To achieve a successful outcome, the health care providers 
need to provide, injection, prevention and harm reduction facilities as early as possible 
among drug users in culturally appropriate manners. Harm reduction services need to 
cover family, friends and networks of drug users who are also using drugs. 
Comprehensive health education for young non injection drug users in regard to negative 
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impacts of drug use especially Buprenorphine which can increase the likelihood of 
injection initiation is important.  
We shouldn’t ignore drug users who have higher education due to a 
misconception that these people, as educated individuals, are not vulnerable to injection. 
According to our study they shouldn’t be missed in our assessment since they are at great 
risk of injection initiation, so they need additional consideration in respect to education 
through using effective methods of intervention that can increase the chance of their 
behavioral change toward injection prevention practices.41  
Besides attempting to prevent injection initiation drug use, intervention strategies 
should target reductions in frequency of drug use. In our study, drug users who used 
drugs four times or more per day were at greater risk of injection initiation as compare to 
drug users who used drug less than four times per day, so, we have to consider frequency 
of drug use as one of our key factors in our assessment for likelihood of injection and try 
to provide different prevention, harm reduction and substance therapy services to reduce 
the frequency of drug use.  
 Previous history of rehabilitation is another predicting factor, which needs to be 
included in every risk assessment for injection initiation. Drug users who have had 
previous history of rehabilitation in prison or government camps are at greater risk of 
injection initiation. These cases need to be identified and covered by harm reduction and 
substance therapy intervention to reduce the chance of injection initiation in near future. 
Moreover, all prisons need to provide hard reduction and other substance therapy services 
for prisoners who use drugs and are seeking for substance therapy or recovery.  
	  39	  	  
Furthermore, the results of our study will be summarized and shared with all key 
stakeholders to inform them with respect to importance of injection initiation which can 
increase risk of exposure to HIV/AIDS and other blood borne diseases. If the accuracy of 
these results is accepted by policy makers, the new harm reduction and substance therapy 
policy will be incorporated into health care settings which can help implement and extend 
injection drugs prevention programs in the entire Kermanshah province to target 
aforementioned predicting risk factors among drug users who are at greater risk for 
injection initiation. The implications of the present findings in different socio-economic 
locations within some cities in Kermanshah can be generalized to the provincial level and 
are significant also at a national level. They are important for all policy-makers seeking 
to initiate dependency prevention educational programs among young generation with 
focus on drug users who are more educated with high frequency of drug use or previous 
history of rehabilitation in prison as a more vulnerable population. Responsible impact 
assessment needs to involve decision makers in order to motivate their interests in the 
project being tested. It is essential to consult the proceedings of deliberative bodies 
(government committee hearings or legislative debates) and meet with decision makers. 
The results of our study will address the values of persons engaged in policymaking, 
program planning, and management. The generalizability of new strategies for harm 
reduction program fits needs of entire drug users, who are at greater risk for injection 
initiation.42 
The results of this study and the evidence of injection drug’s devastation on a 
population can force legislators to pass some regulations and mandate the government to 
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implement some regulations and actions to reduce or prevent the risk of injecting drugs 
among drug users and to prohibit arrestment or imprisonment of drug users anymore 
which may increase risk of HIV/AIDS and other blood borne diseases and to replace this 
approach with referring drug users to clinics to receive substance therapy and harm 
reduction services. Much can be learned from the policy and program strategies used in 
comprehensive tobacco control.43 
Effective educational programs for providing harm reduction and substance 
therapy at early stages of drug use focusing on risk factors associated with injection 
initiation among young educated drug users can be fueled by broad based community 
efforts with involvement of parents, mass media, and community organizations and also 
by targeting the social policy or social environment and individual knowledge, attitudes, 
and behaviors for change of high risk behaviors which may put drug users at greater risk 
for injection initiation. Overall, the outcome of this study can encourage policy makers of 
Iran to extend harm reduction policy to high-risk NIDU populations. 
Limitations of this Study 
Research has identified that changes in policies and environmental factors that 
support specific recommended health behaviors are important to achieve and sustain 
beneficial lifestyle behaviors.44 One limitation of this study is that it does not consider 
any of these changes that are specific to dependency and might have impacted the 
changes observed in the behavior of the study population over-time. Since data on these 
factors was not collected in this study the analysis might include residual confounding 
due to these factors.  
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Another possible source of limitation is the use of self-report for most measures, 
and due to the retrospective nature of the collected information the data might suffer from 
the poor recall of the subjects. However, since it is unlikely that cases and controls have 
differential recall, the bias is only non-differential and towards the null, only dampening 
the overall effect observed. Furthermore, no biochemical verification of dependency 
status was performed.43, 45 and although confidentially was emphasized, subjects may 
have underreported their unprotected behaviors.43 These factors all could lead to further 
non-differential misclassification of the exposures and outcome measures, which could 
lead to a bias towards the null effect. 
Other limitations include the generalizability of the study results, which are 
related to representativeness of the study sample selected. Drug users in this study were 
considered to be more hard-core users as they were recruited from a major drug treatment 
and rehabilitation center according to their high-risk profile. Thus, selection bias is 
indeed an issue in regards to the participation of the subjects in the study. However, the 
selection bias is also not likely to be differential, and at most there is a dampening of 
effect observed. Most importantly, caution must be taken when generalizing the results 
into the larger populations, as the results are only applicable to the Kurdish population, 
living in Kermanshah city of Iran, seeking treatment from the specific facilities, during 
the specified time period of this study.    
Conclusion 
In this study, the contextual social and behavioral factors are assessed and further 
analysis has identified these factors based on the time period during which subjects 
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initiated drug use. Indeed, it was observed that the significance of certain risk factors, 
such as level of education, or history of rehabilitation in prisons may change over time as 
a result of the constantly changing political, economic, social, and environmental milieu.  
The strongest risk factors associated with increased rates of injection drug use in 
the current study are younger age, the use of buprenorphine as a gateway drug, drug use 
frequency equal to or exceeding four times per day, and a history of drug use cessation in 
prison or government camps. The implication of injection drug use is particularly 
significant in the spread of HIV/AIDS in Iran and drug use remains the most prevalent 
mode of the spread of HIV in Iran, despite the increasing prevalence of sexual 
transmission. The results of this study can help in the design of harm reduction strategies 
at multiple levels in order to improve national drug policies. For instance, the 
significance of some social factors such as education or personal factors like history of 
rehabilitation in prison may be dismissed during the time due to impact of other 
environmental factors such as level of access to drug or substance therapy inside prison. 
So, the contextual factors during a certain time period when an individual initiates 
injection, is a key factor, which needs to be considered as the first, step in any risk factor 
evaluation for injection.  
Identifying the risk factors, which facilitate injection initiation, can help us to 
design more effective strategies to prevent NIDUs from becoming IDUs and enables us 
to target these factors in order to provide harm reduction to those who have yet to inject.
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APPENDIX 
 
QUESTIONNARE 
 
Center of reception and follow up of self-introduced Addicts, Province: ………… 
City: …….. 
 
Name and Surname [reference]: ……………….      
   Code: ……… 
Exact address: …………………………………………. (Ask at the end of interview) 
 Name and surname of interviewer: ……….. 
Tel: …………………. (Ask at the end of interview)      
   Date:  cccccc 
 
1 Age: cc 
 
2 Gender  1- Male c 2-Female: c 
 
3 Permanent Location:  1- City (write it) c… . ….2- Village c (Respective city's 
name is mentioned) …….. 
 
4 Place of Birth:  1- City (write it) c… . ….2- Village c (Respective city's name is 
mentioned) …… 3- Abroad ( The name of country must be mentioned) ……. 
 
5 What is your job? (You can select multiple options) …………………………….. 
1- Student c  2-University Student c  3-Housekeeperc  4- Soldierc  5-Laborc  6-
Farmerc  7-Government employees(military)c  8-Government employees(civilian) 
c  9-Shopkeeperc  10-Retiredc  11-Unemployedc  12-Other(write it) c …….. 
 
6 What is your education level? 
1-Unseducatedc  2-Able to read and writec  3-Elementary school onlyc  4-Junior 
Schoolc  5-Diplomac  6-Associated degreec  7-Bachelorc  8-Mastersc  9-
Doctorate(PhD)c  10-Religions studiesc  11- Other(write it) c …….. 
 
7 What is your marital status? 
1-Singlec 2-Marriedc  3-Abandonmentc  4-Divorcedc  … times  5-Widowc  6-
Temporery Marriagec  7-Remarriagec …times  8-Polygamyc  9-Other(write it) c 
… 
 
8 How many children do you have?  cc 
 
9 How is your housing status? 
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1-Home ownerc  2-Rental homec 3-Living in father's housec  4-Living in father in 
law housec  5-Residential housec  6-Other (write it) c … 
 
10 What is your average total monthly income (Tooman)? cccccccc 
 
11 What is the reason for your visit? (Read the answers , select multiple options) 
1-Physical side effects of drugsc  2-Psychological side effects of drugsc 3-
Financial problemsc  4-Legal problemsc  5-Pregnancyc  6-Pressure(family, Wife, 
Friends) c  7-Social problemsc  8-Other (write it) c 
 
12 Do you have any history of smoking (either past or present)?  1-Yes, in the pastc  
2-Yes, in the presentc  3-Noc 
 
13 At what age did you start smoking cigarette/Tobacco? 
1-Under 10 years oldc  2-Between 10-14 yearsc  3- Between 15-19 yearsc  4- 
Between 20-24 yearsc  5- Between 25-29 yearsc  6 Between 30-34 yearsc  7- 
Between 35-39 yearsc  8- Between 40-44 yearsc  9-Above 45 yearsc 
 
14 What kind of drug (or drugs) do you use now? 
1-Marijuanac   2-Opium sapc  3-Opiumc  4-Heroinc  5-Alchoholc  6-Other (Write 
it) c ……… 
 
15 How do you use drugs? ( You can select multiple options) 
1-Smokingc  2-Swallowingc  3-Injectionc  4-Drinkingc  5-Enemac  6-Snortingc 
 
16 How often do you use drugs on average? 
1-Four times or more per dayc  2-Two or three times per dayc  3-Once a dayc 4-
Two to six times per dayc 5-Once a week or lessc 
 
17 How much drug do you use in 24 hours? Marijuana …………….. Cigarette 
Opium ………………… Ounces   
Heroin ………………… Grams 
Alcohol …………………… 
Other ………………….  
 
18 How much money do you spend to getting the drugs? 
1-Less than 1000 Toomansc  2- 1001-3000 Toomansc  3- 3001-7000 Toomansc  
4-7001-12000 Toomansc  5-12001-18000 Toomansc  6- More than 18001 
Toomansc 
 
19 What was the first drug that you used? ( If the first was Alcohol, Please notify the 
second) 
1-Marijuanac   2-Opium sapc  3-Opiumc  4-Heroinc  5-Alchoholc  6-Other (Write 
it) c ……… 
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20 At what age did you start using drug? 
1-Alcohol:  cc 
2-Other :cc 
 
21 Who suggest you to use the drugs for the first time (Except cigarette and alcohol)? 
(Read the answers) 
1-A family memberc  2- A relativec 3-(school) Friends c  4-(outside School) 
Friends or work colleagues c 5-Strangers c 6-Otherc 
 
22 Where did you start using drugs for the first time? 
1-Family’s Partiesc  2-Friends’ Partiesc  3-At Parkc  4-At Schoolc 5-In the streetc 
6-In Military c 7-At Officec 
 
23 Did anybody in your family use any drugs before you started it (Except cigarette 
and alcohol)?  1-Yesc  2-Noc 
 
24 Who? (You can select multiple options) 
1-Spous /Partnerc 2-Fatherc 3-Motherc 4-Sisterc 5-Brother c 6- Child c 
 
25 Which drugs have you used until now? ( You can select multiple options) 
 
26 Have you ever used shared needle for injection?  1- Yesc  2-Noc 
 
27 Have you ever quit drugs (except alcohol and cigarette)? 1-Yesc  2-Noc 
 
28 How many times: cc 
 
29 How long was the largest period of quitting period? 
1-Less than one week c  2-one to four weeksc 3-one to three monthsc  4-three 
months and one day to six monthsc  5-Six months and one day to twelve months c  
6-One year and one day to three yearsc  7-Three years and one day to five yearsc  
8-More than five years ( write it) c ….  
 
30 How did you quit the drug? ( Read the answers, you can choose multiple options) 
1-Individuallyc  2-Outpation visit in private centersc  3-Inpatient Visit in private 
centersc  4-Outpatient visit in governmental centersc  5-Stay in drug rehabilitation 
centers c  6- Stay in camps or prisonsc  7-Other (write it) 
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